Product NDC: | 63323-142 |
Proprietary Name: | Ifosfamide |
Non Proprietary Name: | IFOSFAMIDE |
Active Ingredient(s): | 1 g/1 & nbsp; IFOSFAMIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-142 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076078 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030128 |
Package NDC: | 63323-142-10 |
Package Description: | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (63323-142-10) |
NDC Code | 63323-142-10 |
Proprietary Name | Ifosfamide |
Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (63323-142-10) |
Product NDC | 63323-142 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | IFOSFAMIDE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20030128 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | IFOSFAMIDE |
Strength Number | 1 |
Strength Unit | g/1 |
Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |